New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 19, 2014
09:59 EDTMIND, ESV, PAY, KMB, DTV, THR, GNW, DB, AZN, ATK, CHA, ARCP, CTL, MOOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: ATK (ATK) downgraded to Neutral from Buy at Goldman... Altria Group (MO) downgraded to Market Perform from Outperform at Wells Fargo... American Realty (ARCP) downgraded to Neutral from Outperform at RW Baird... AstraZeneca (AZN) downgraded to Market Perform from Outperform at Leerink... CenturyLink (CTL) downgraded to Equal Weight from Overweight at Morgan Stanley... China Telecom (CHA) downgraded to Neutral from Buy at Goldman... Deutsche Bank (DB) downgraded to Underperform from Neutral at BofA/Merrill... DirecTV (DTV) downgraded to Hold from Buy at Wunderlich... Ensco (ESV) downgraded to Hold from Buy at Jefferies... Genworth (GNW) downgraded to Underweight from Equal Weight at Morgan Stanley... Kimberly Clark (KMB) downgraded to Hold from Buy at Argus... Mitcham Industries (MIND) downgraded to Accumulate from Buy at Global Hunter... Thermon Group (THR) downgraded to Hold from Buy at KeyBanc... VeriFone (PAY) downgraded to Neutral from Positive at Susquehanna.
News For ATK;MO;ARCP;AZN;CTL;CHA;DB;DTV;ESV;GNW;KMB;MIND;THR;PAY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
March 24, 2015
06:34 EDTKMBKimberly-Clark upgraded to Outperform from Market Perform at Wells Fargo
Subscribe for More Information
06:18 EDTPAYVerifone initiated with an Outperform at BMO Capital
Target $42.
March 23, 2015
09:45 EDTAZNUBS to hold a field trip
Subscribe for More Information
09:06 EDTAZNInsmed appoints Eugene Sullivan as Chief Medical and Scientific Officer
Subscribe for More Information
09:03 EDTAZNLeerink analysts hold a meeting with a conference call hookup
Subscribe for More Information
09:00 EDTGNWGenworth upgraded at Raymond James
Subscribe for More Information
08:13 EDTDTVPendrell unit: Court rejects attempts to limit scope of DRM patents
ContentGuard Holdings, a subsidiary of Pendrell Corporation (PCO), announced that on Friday, March 20, Judge J. Rodney Gilstrap of the U.S. District Court for the Eastern District of Texas issued a 144 page Claim Construction Order in lawsuits ContentGuard filed against several companies who continue to use its patented Digital Rights Management solutions without a license, including Apple (AAPL), Amazon.com (AMZN), DirecTV (DTV), Google (GOOG), HTC, Huawei, Motorola Mobility and Samsung Electronics (SSNLF). In his order, Judge Gilstrap interpreted the language in ContentGuard’s patents in a manner that fully preserves the breadth of ContentGuard’s patented Digital Rights Management technologies. These technologies were developed to enable the distribution of digital media over the Internet and other networks, including cellular and satellite networks, and provide innovative solutions to problems that were once thought to be unsolvable. “We are very pleased with the Court’s ruling,” commented James Baker, ContentGuard’s Vice President for Licensing and Strategic Development. “We believe these claim constructions demonstrate that the online stores defendants provide for buying and renting DRM-protected movies, videos, books, and music and devices that play, run, display or print this DRM-protected content infringe ContentGuard’s pioneering DRM patents.”
07:36 EDTAZNPfizer should rise 'significantly' over next two years, says Jefferies
Jefferies analyst Jeffrey Holford told investors this morning that he expects shares of Pfizer (PFE) to appreciate "significantly" over the next two years. A survey of U.S. oncologists indicated the company's Ibrance drug will be used in 50% of first line hormonal therapy within one year, with off-label use in all lines of therapy including adjuvant, Holford noted. He thinks peak sales of the drug could top $13B, which is well above consensus. In addition, the analyst views Pfizer's Global Established Pharmaceutical business as being underappreciated by the market. Potential value creating options for the pharmaceutical giant include spinning off its GEP unit by 2017 and accretive acquisitions, with possible takeover targets being Shire (SHPG), Actavis (ACT), AstraZeneca (AZN) and GlaxoSmithKline (GSK), in the eyes of Holford. He added the stock to the firm's Franchise Picks list, which encompasses its best ideas. He also raised his price target for Pfizer to $45 from $42. The stock closed Friday up 10c to $34.25.
07:20 EDTPAYBarclays to hold a forum
Subscribe for More Information
06:59 EDTMOBig Tobacco accused of trying to dampen e-cigarette sales, Reuters says
Subscribe for More Information
06:50 EDTGNWGenworth upgraded to Strong Buy from Outperform at Raymond James
March 22, 2015
18:14 EDTDBDeutsche Bank revamp to impact retail operations, Reuters says
The planned restructuring by Deutsche Bank will have the most impact on the bank's retail operations, says Reuters. According to sources, the bank's retail operations will "bear the brunt" of the revamp and will most likely be spun off in a stock market listing, added Reuters. Reference Link
17:51 EDTDBLawsky targets Deutsche Bank in Libor probe, FT says
According to people familiar with the matter, New York state's financial services regulator Benjamin Lawsky has joined other regulators investigating Deutsche Bank for manipulation of the Libor benchmark borrowing rate, says the Financial Times. Reference Link
March 20, 2015
07:55 EDTAZNAstraZeneca seen as potential target again if oncology drugs lag, Bloomberg says
Subscribe for More Information
07:17 EDTDBDeutsche Bank investors pushing for Postbank sale, Financial Times says
Subscribe for More Information
06:24 EDTCHAChina Mobile capex outlook negative for Xilinx, Altera, says Citigroup
Citigroup says the lower 2015 capital expenditure guidance from China Mobile (CHL) is negative for Xilinx (XLNX) and Altera (ALTR) since it offsets the higher spending at China Telecom (CHA) and China Unicom (CHU). Citi sees downside to consensus estimates for both Xilinx and Altera and keeps Neutral ratings on the stocks.
March 19, 2015
10:42 EDTARCPOptions with decreasing implied volatility
Subscribe for More Information
08:37 EDTAZNNektar and Daiichi Sankyo to commercialize Movantik in the U.S.
Subscribe for More Information
March 18, 2015
12:24 EDTCHAChina Telecom upgraded to Overweight from Equal Weight at Barclays
07:30 EDTDTVAT&T-DirecTV getting less attention than Comcast-Time Warner Cable, Reuters says
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use